Literature DB >> 35923536

A case of hypertrophic cardiomyopathy with right ventricular outflow tract and left midventricular obstruction.

Natsumi Okada1, Atsushi Shibata1, Akiko Tanihata1, Ryoko Kitada1, Shoichi Ehara1, Yasuhiro Izumiya1.   

Abstract

We describe a case of a 59-year-old woman with hypertrophic cardiomyopathy who remained with right ventricular outflow tract obstruction after the pressure gradient in the left midventricle was resolved by a drug with a negative inotropic effect. The patient was diagnosed with hypertrophic cardiomyopathy 30 years previously and was only on low-dose beta-blocker therapy. She presented at our hospital with suspected exacerbation of heart failure because of the development and exacerbation of dyspnea and chest tightness. Transthoracic echocardiography showed an accelerated blood flow of 3 m/s in the middle of the left ventricle; thus, she was started on cibenzoline, a drug with a negative inotropic effect. After admission, intracardiac pressure measurement showed no pressure gradient in the left chamber. However, there was a pressure gradient of 18 mmHg between the apex of the right ventricle and the right ventricular outflow tract, and right ventricular outflow tract obstruction was confirmed on cardiac magnetic resonance imaging. We decided to reinforce the negative inotropic effect by adding bisoprolol, and the subjective symptoms and auscultatory systolic murmur were eliminated 2 months later. Learning objective: Hypertrophy of the right ventricular myocardium can occur in patients with hypertrophic cardiomyopathy (HCM). However, right ventricular outflow tract obstruction remains a rare finding in patients with HCM, despite the presence of morphological abnormalities such as right ventricular hypertrophy. In patients with HCM, obstruction of the right ventricle should be considered if the symptoms and auscultatory findings do not match the left ventricular imaging findings.
© 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. All rights reserved.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; Midventricular obstruction; Right ventricular outflow tract obstruction

Year:  2022        PMID: 35923536      PMCID: PMC9214872          DOI: 10.1016/j.jccase.2022.02.010

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  9 in total

1.  Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy.

Authors:  Yuichiro Minami; Katsuya Kajimoto; Yutaka Terajima; Bun Yashiro; Dai Okayama; Shintaro Haruki; Takatomo Nakajima; Naomi Kawashiro; Masatoshi Kawana; Nobuhisa Hagiwara
Journal:  J Am Coll Cardiol       Date:  2011-06-07       Impact factor: 24.094

2.  Transcoronary alcohol ablation of infundibular hypertrophy in patients with idiopathic infundibular pulmonic stenosis.

Authors:  S J Park; C W Lee; M K Hong; J K Song; S W Park; J J Kim
Journal:  Am J Cardiol       Date:  1997-12-01       Impact factor: 2.778

3.  Right ventricular remodeling, its correlates, and its clinical impact in hypertrophic cardiomyopathy.

Authors:  Monica Roşca; Andreea Călin; Carmen C Beladan; Roxana Enache; Anca D Mateescu; Maria-Magdalena Gurzun; Paula Varga; Cristian Băicuş; Ioan M Coman; Ruxandra Jurcuţ; Carmen Ginghină; Bogdan A Popescu
Journal:  J Am Soc Echocardiogr       Date:  2015-08-19       Impact factor: 5.251

4.  Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: relation to clinical and prognostic features.

Authors:  W J McKenna; A Kleinebenne; P Nihoyannopoulos; R Foale
Journal:  J Am Coll Cardiol       Date:  1988-02       Impact factor: 24.094

5.  Right ventricular outflow stent implantation: an alternative to palliative surgical relief of infundibular pulmonary stenosis.

Authors:  J L Gibbs; O Uzun; M E Blackburn; J M Parsons; D F Dickinson
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

6.  Right ventricular obstruction in various types of hypertrophic cardiomyopathy.

Authors:  U Stierle; A Sheikhzadeh; J G Shakibi; A F Langbehn; K W Diederich
Journal:  Jpn Heart J       Date:  1987-01

7.  Right ventricular involvement in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Thomas H Hauser; Ethan Dubrow; Taylor A Horst; Kraig V Kissinger; James E Udelson; Warren J Manning
Journal:  Am J Cardiol       Date:  2007-08-09       Impact factor: 2.778

8.  Echocardiographic assessment of right ventricular obstruction in hypertrophic cardiomyopathy.

Authors:  Masatoshi Shimizu; Hiroya Kawai; Yoshiyuki Yokota; Mitsuhiro Yokoyama
Journal:  Circ J       Date:  2003-10       Impact factor: 2.993

9.  The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy.

Authors:  Xiying Guo; Chaomei Fan; Lei Tian; Yanling Liu; Hongyue Wang; Shihua Zhao; Fujian Duan; Xiuling Zhang; Xing Zhao; Fengqi Wang; Hongguang Zhu; Aiqing Lin; Xia Wu; Yishi Li
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.